January 4th, 2013
Missouri Board Issues Emergency Suspension of Cardiologist Accused of Implanting Unnecessary Stents
Larry Husten, PHD
A Missouri cardiologist who has been accused of unnecessarily implanting stents in six patients has been temporarily barred from seeing patients. The Missouri State Board of Registration for the Healing Arts, which licenses physicians and investigates and disciplines physicians in cases of accused misconduct, issued an emergency suspension of the cardiologist’s license to practice, according to a […]
January 3rd, 2013
Combination of Ezetimibe and Atorvastatin Back on FDA Approval Path
Larry Husten, PHD
A combination tablet containing the cholesterol-lowering drugs ezetimibe and atorvastatin is back on the path to possible FDA approval, according to Merck, which already markets Zetia (ezetimibe) and Vytorin, the combination of ezetimibe and simvastatin. Merck has repeatedly stumbled in its efforts to gain FDA approval of the proposed new drug, which has been dubbed “Son […]
January 2nd, 2013
CABG Highly Cost-Effective in Diabetics with Multivessel Disease
Larry Husten, PHD
In November the main results of the FREEDOM trial showed that diabetics with multivessel disease do better with CABG than PCI. Now the findings of the trial’s cost-effectiveness study, published online in Circulation, demonstrate that CABG is also highly cost-effective when compared with PCI. Elizabeth Magnuson and colleagues found that although CABG initially cost nearly $9000 more than PCI […]